# 19AQMM26F1521 - Sole Source Justification Under Federal Supply Schedule: 20262027 Flu vaccines

Canonical: https://abierto.us/opportunities/19aqmm26f1521

- Solicitation number: 19AQMM26F1521
- Notice type: Justification
- Status: Awarded to Glaxosmithkline, LLC
- Department: Department of State
- Contracting office: Acquisitions - Aqm Momentum (19AQMM)
- NAICS: 325412 Pharmaceutical Preparation Manufacturing
- Product or service code: 6505 Drugs and Biologicals
- Place of performance: Durham, North Carolina
- Who can bid, by location: Anywhere in the US. Location does not limit who can bid: a product shipped to the buyer, research at the performer's facility, or work at the contractor's site. A state shown is the delivery point.
- County: Durham County (FIPS 37063). https://abierto.us/counties/durham-county-nc-37063
- City: Durham. https://abierto.us/cities/durham-nc-3719000
- First posted: October 21, 2026
- Last posted: October 21, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/7b22f9e4f4554a2d99e95e46286847c7/view

## Description

Annual delivery order issued on a sole-source basis from the Department of Veteran’s Affairs Glaxosmith Kline federal supply schedule for pharmaceuticals and vaccines. The specific contract number is 36F79722D0178. The delivery order will be for proprietary Fluarix and Flulaval Influenza vaccines.

## Attachments

- [GSK Sole Source Justification Under Federal Supply Schedule.pdf_signed_Redacted SAM.gov_Redacted.pdf](https://sam.gov/api/prod/opps/v3/opportunities/resources/files/9545e55f30fe4c72b35ede5490f4825e/download)

## Award on USAspending

- Recipient: Glaxosmithkline, LLC (UEI FRHTPHMZMX47)
- Contract: 19AQMM26F1521 under 36F79722D0178, delivery order
- Obligated: $686,968.00
- Competition: Full and Open Competition, 1 offers received
- Link: award number 19AQMM26F1521 equals the contract number; same awarding office 19AQMM (high confidence)
- Record: https://www.usaspending.gov/award/CONT_AWD_19AQMM26F1521_1900_36F79722D0178_3600/


## Open now in the same industry

9 open in NAICS 325412.

- FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 (36C25027Q0052), due November 3, 2026 at 9:00 AM EST. https://abierto.us/opportunities/36c25027q0052
- Sacubitril/Valsartan Tablets (VA-27-00014055) (36E79727R0007), due November 3, 2026 at 3:30 PM EST. https://abierto.us/opportunities/36e79727r0007
- LIDOCAINE 5% PATCHES-REQUEST FOR INFORMATION (36C77027Q0010), due November 3, 2026 at 6:00 PM EST. https://abierto.us/opportunities/36c77027q0010

## Publications

- October 21, 2026: Justification. Notice 7b22f9e4f4554a2d99e95e46286847c7. https://sam.gov/workspace/contract/opp/7b22f9e4f4554a2d99e95e46286847c7/view

## Points of contact

- Lesley A. Stewart, StewartLA@state.gov

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/19aqmm26f1521.